In-Silico Analysis of Costunolide and Dehydrocostuslactone Interactions with NAFLD-Related Proteins
DOI:
https://doi.org/10.55018/janh.v7i2.361Keywords:
Costunolide, Dehydrocostuslactone, Non-alcoholic Fatty Liver Disease, NF-κB, Saussurea costusAbstract
Background: Non-alcoholic Fatty Liver Disease (NAFLD) is a growing health problem, but there is no standard drug for its treatment. Costunolide and dehydrocostuslactone are compounds found in Saussurea costus, exhibiting antioxidant activities that include anti-hepatotoxic, anti-inflammatory, and immunostimulant properties, which have been proven both in vivo and in vitro. This study aims to identify the bioactive ingredients of S. costus that affect NAFLD and explore its therapeutic targets through pharmacological networking. Various tissue databases were utilised to obtain the bioactive material from S. costus and identify potential therapeutic targets for NAFLD. Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) were used to enrich the functions and molecular pathways of common targets.
Methods: The analysis was conducted using a Structure-Activity Relationship (SAR) search to evaluate the biological potential of the studied compounds. The design of this study involved selecting costunolide and dehydrocostuslactone compounds as the subjects of analysis, with data collection conducted through public databases and relevant literature. SAR assessment was conducted using reporting standards, such as STITCH, to ensure transparency and reproducibility in the analysis. The score range used was 0-1, where the closer to 1, the better the value obtained. This process allows the identification of significant relationships between chemical structure and biological activity, as well as providing deeper insight into the potential of the compounds analysed. Thus, this method not only assesses the effectiveness of the compound but also provides a basis for further research in the development of therapy
Results: The results of the Structure-Activity-Relationship (SAR) analysis were that the costunolide and dehydrocostuslactone compounds had scored <0.5 as a hepatoprotector and as a regulator of fat metabolism. The potential of these two compounds as TNF-alpha inhibitors and Interleukin-6 antagonists also shows a score <0.5.
Conclusion: Costunolide and dehydrocostuslactone showed significant potential as anti-inflammatory agents and NF-κB transcription inhibitors. These findings indicate that both compounds may be promising candidates for NAFLD therapy, particularly through the mechanism of inhibition of the NF-κB transcription pathway. The implications of these results suggest the need for further studies to explore the efficacy and safety of these compounds in a clinical context, as well as their potential in the development of novel therapies for non-alcoholic fatty liver disease.
Downloads
References
Abdulqahar, F. W., & Hussein, F. F. (2023). In-Silico Anti-SARS-CoV-2 Activity of Different Bioactives Green-Extracted from the Medicinal Plant Saussurea lappa Clarck. IOP Conference Series: Earth and Environmental Science, 1262(5), 52014. https://doi.org/10.1088/1755-1315/1262/5/052014
AlSaadi, B. H., AlHarbi, S. H., Ibrahim, S. R. M., El-Kholy, A. A., El-Agamy, D. S., & Mohamed, G. A. (2018). Hepatoprotective activity of Costus speciosus (Koen. Ex. Retz.) Against paracetamol induced liver injury in mice. African Journal of Traditional, Complementary and Alternative Medicines, 15(2), 35–41. https://doi.org/10.21010/ajtcamv15i2.5
Barghchi, H., Milkarizi, N., Belyani, S., Norouzian Ostad, A., Askari, V. R., Rajabzadeh, F., Goshayeshi, L., Ghelichi Kheyrabadi, S. Y., Razavidarmian, M., & Dehnavi, Z. (2023). Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: A randomized double-blind clinical trial. Nutrition Journal, 22(1), 40. https://link.springer.com/article/10.1186/s12937-023-00869-2
Beiriger, J., Chauhan, K., Khan, A., Shahzad, T., Parra, N. S., Zhang, P., Chen, S., Nguyen, A., Yan, B., & Bruckbauer, J. (2023). Advancements in understanding and treating NAFLD: a Comprehensive Review of Metabolic-Associated fatty liver disease and emerging therapies. Livers, 3(4), 637–656. https://doi.org/10.3390/livers3040042
Belahcene, S., Kebsa, W., Omoboyowa, D. A., Alshihri, A. A., Alelyani, M., Bakkour, Y., & Leghouchi, E. (2023). Unveiling the chemical profiling antioxidant and anti-inflammatory activities of algerian Myrtus communis L. essential oils, and exploring molecular docking to predict the inhibitory compounds against cyclooxygenase-2. Pharmaceuticals, 16(10), 1343. https://doi.org/10.3390/ph16101343
Berardo, C., Di Pasqua, L. G., Cagna, M., Richelmi, P., Vairetti, M., & Ferrigno, A. (2020). Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: current issues and future perspectives in preclinical and clinical research. International Journal of Molecular Sciences, 21(24), 9646. https://doi.org/10.3390/ijms21249646
Byrne, C. D., & Targher, G. (2020). What’s new in NAFLD pathogenesis, biomarkers and treatment? Nature Reviews Gastroenterology & Hepatology, 17(2), 70–71. https://www.nature.com/articles/s41575-019-0239-2
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328–357. https://doi.org/10.1002/hep.29367
Chen, Y., Zheng, H., Zhang, J., Wang, L., Jin, Z., & Gao, W. (2016). Reparative activity of costunolide and dehydrocostus in a mouse model of 5-fluorouracil-induced intestinal mucositis. RSC Advances, 6(7), 5249–5258. https://pubs.rsc.org/en/content/articlelanding/2016/ra/c5ra22371g/unauth
Devillers, J., & Devillers, H. (2024). Structure–Activity Relationship (SAR) Modeling of Mosquito Repellents: Deciphering the Importance of the 1-Octanol/Water Partition Coefficient on the Prediction Results. Applied Sciences, 14(13), 5366. https://doi.org/10.3390/app14135366
Flieger, J., Flieger, W., Baj, J., & Maciejewski, R. (2021). Antioxidants: Classification, natural sources, activity/capacity measurements, and usefulness for the synthesis of nanoparticles. Materials, 14(15), 4135. https://doi.org/10.3390/ma14154135
Godoy-Matos, A. F., Silva Júnior, W. S., & Valerio, C. M. (2020). NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetology & Metabolic Syndrome, 12, 1–20. https://link.springer.com/article/10.1186/s13098-020-00570-y
Han, S. K., Baik, S. K., & Kim, M. Y. (2022). Non-alcoholic fatty liver disease: Definition and subtypes. Clinical and Molecular Hepatology, 29(Suppl), S5. https://doi.org/10.3350/cmh.2022.0424
Jubayer, M. F., Kayshar, M. S., Arifin, M. S., Das, P. C., Mazumder, M. A. R., & RAHMAN, M. D. M. (2023). Therapeutic Potential of Selective Medicinal Plants and Their Phytoconstituents Focusing the Prevention and Cure of COVID-19. https://osf.io/preprints/ekf8n/
Karamalakova, Y. D., Nikolova, G. D., Georgiev, T. K., Gadjeva, V. G., & Tolekova, A. N. (2019). Hepatoprotective properties of Curcuma longa L. extract in bleomycin-induced chronic hepatotoxicity. Drug Discoveries & Therapeutics, 13(1), 9–16. https://doi.org/10.5582/ddt.2018.01081
Lestari, D. L., Jurnalis, Y. D., & Ali, H. (2021). Hubungan Kadar Docosahexaenoic Acid Terhadap Perlemakan Hati Non Alkoholik Remaja Obesitas. Sari Pediatri, 23(2), 82–87. https://doi.org/10.14238/sp23.2.2021.82-7
Liu, B., Rong, Y., Sun, D., Li, W., Chen, H., Cao, B., & Wang, T. (2019). Costunolide inhibits pulmonary fibrosis via regulating NF-kB and TGF-β1/Smad2/Nrf2-NOX4 signaling pathways. Biochemical and Biophysical Research Communications, 510(2), 329–333. https://doi.org/10.1016/j.bbrc.2019.01.104
Liu, X., Li, H., Wang, S., Zhang, J., & Liu, D. (2021). Sesquiterpene lactones of Aucklandia lappa: Pharmacology, pharmacokinetics, toxicity, and structure–activity relationship. Chinese Herbal Medicines, 13(2), 167–176. https://doi.org/10.1016/j.chmed.2020.11.005
Mishra, V., Tomar, S., Yadav, P., Vishwakarma, S., & Singh, M. P. (2022). Elemental analysis, phytochemical screening and evaluation of antioxidant, antibacterial and anticancer activity of Pleurotus ostreatus through in vitro and in silico approaches. Metabolites, 12(9), 821. https://doi.org/10.3390/metabo12090821
Nadda, R. K., Ali, A., Goyal, R. C., Khosla, P. K., & Goyal, R. (2020). Aucklandia costus (syn. Saussurea costus): Ethnopharmacology of an endangered medicinal plant of the Himalayan region. Journal of Ethnopharmacology, 263, 113199. https://doi.org/10.1016/j.jep.2020.113199
Noor, F., Tahir ul Qamar, M., Ashfaq, U. A., Albutti, A., Alwashmi, A. S. S., & Aljasir, M. A. (2022). Network pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals, 15(5), 572. https://doi.org/10.3390/ph15050572
Parlati, L., Régnier, M., Guillou, H., & Postic, C. (2021). New targets for NAFLD. JHEP Reports, 3(6), 100346. https://doi.org/10.1016/j.jhepr.2021.100346
Setiono, D. D., Wantania, F. E. N., & Polii, E. B. I. (2022). Risk Factors of Non-Alcoholic Fatty Liver Disease in Adults. E-CliniC, 10(2), 234–241. https://doi.org/10.35790/ecl.v10i2.37814
Shati, A. A., Alkahtani, M. A., Alfaifi, M. Y., Elbehairi, S. E. I., Elsaid, F. G., Prasanna, R., & Mir, M. A. (2020). Secondary Metabolites of Saussurea costus Leaf Extract Induce Apoptosis in Breast, Liver, and Colon Cancer Cells by Caspase‐3‐Dependent Intrinsic Pathway. BioMed Research International, 2020(1), 1608942. https://doi.org/10.1155/2020/1608942
Tejaswi, J. K. D., Rajan, R. G., & Sara, P. (2018). Biological evaluation of Saussurea lappa root extract for analgesic and anti-inflammatory activity. Asian Journal of Pharmaceutical Research and Development, 6(4), 35–38. https://doi.org/10.22270/ajprd.v6i4.378
Toda, Y., Shigemori, H., Ueda, J., & Miyamoto, K. (2017). Isolation and identification of polar auxin transport inhibitors from Saussurea costus and Atractylodes japonica. Acta Agrobotanica, 70(3). https://pbsociety.org.pl/journals/index.php/aa/article/view/aa.1700
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Fransiska Ambarukmi Pontjosudargo, Hendri Priyadi, Agung Hermawanto, Tatang Bisri
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
